The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Funding of PBTCF 2020: PBTC-058 - $25,000

Amount
$25,000.00
Date
January 2020

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Sydney Children's Hospital - $151,468

Amount
$151,468.00
Date
December 2019

Developing New Epigenetic Combination Treatments Against DIPG.

Oncoceutics ONC201 - $100,000

Amount
$100,000.00
Date
December 2019

Expansion of the ONC201 Compassionate Use.

University of Sydney - $100,000

Amount
$100,000.00
Date
November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

University of Michigan Hospitals - $157,856

Amount
$157,856.00
Date
November 2019

Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG

Dayton Children's Hospital - $69,600

Amount
$69,600.00
Date
November 2019

Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.

Institute of Cancer Research - $121,863

Amount
$121,863.00
Date
November 2019

Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.

Bambino Gesu Children's Hospital - $49,803

Amount
$49,803.00
Date
August 2019

Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.

Telethon Kids Institute - $49,512

Amount
$49,512.00
Date
August 2019

Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.

Oncoceutics ONC201 - Phase II - $83,333

Amount
$83,333.00
Date
May 2019

Expansion of the ONC201 Compassionate Use.

Funding of PBTCF 2019: PBTC-058 - $25,000

Amount
$25,000.00
Date
January 2019

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Sydney Children’s Hospital - $175,089

Amount
$175,089.00
Date
November 2018

Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital - $540,742

Amount
$540,742.00
Date
November 2018

Expansion of the International DIPG Registry.

Bambino Gesú Children's Hospital - $99,382

Amount
$99,382.00
Date
November 2018

Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.

Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000

Amount
$35,000.00
Date
November 2018

Credentialing an Improved DIPG Mouse Model.